In Loving memory of McCoy Moretz, M.D., former CEO/CMO/Director and Co-Founder
Professor Richard L. Chang, Inventor/CSO
Inventor and patent holder of multiple indications. He has authored 124 peer-reviewed journal publications; has filed multiple significant patents for the treatment of cancer, Infectious disease, hematology and neurological disorders; and has presented over 150 scientific abstracts. Prof. Chang has over 50 years of research experience with such companies as Hoffman-La-Roche, Schering Corp and Burroughs Wellcome and a full professor and director of Biochemical Pharmacology Research Laboratories at Rutgers University. He successfully launched and completed off IND and IND phase I trials in China and the US.
Ben Chang, CEO/CFO/Chairman
Mr. Ben Chang has previously been founder, director, CEO, President, CFO and/or COO of such biotech companies as Biosuccess Biotech Co. LTD., Rich Pharmaceuticals, Inc., and HypGen, Inc. Mr. Chang started his life-science career as the founder and managing partner of Rich Industries Inc. and Sun-Rich Chemicals, distribution organization and product development companies for nutraceuticals and sport nutrition. Mr. Chang has over 26 years of pharmaceutical and executive level experience. Mr. Chang also has experience in international banking, venture capital, M&A, finance, go-public transactions and organizational design and operations. Mr. Chang has a Bachelor of Science Degree in Economics from East Carolina University where he focused on accounting and international business.
Sean O’Connell, Ph.D, CMO
Dr. O’Connell has served as CSO, CMO, Chief Scientist, SVP, and Founder of multiple pharmaceutical and research companies such as Novartis Pharmaceuticals, Vertical Spine, LLC., Cascade Medical Enterprises, and Integrated Communications Corp. (ICC/IPG). He has authored over 65 peer-reviewed publications and abstracts, has received numerous research grants and has more than 35 years of experience in immunology, cell biology, regenerative medicine, and tissue repair. Hecurrently holds the position of Adjunct Professor in the Department of Vascular Surgery, Englewood Hospital and Medical Center, Mount Sinai School of Medicine, New York.He received his Ph.D in immunology and molecular biology from Rutgers University and the University of Medicine and Dentistry of New Jersey at New Brunswick (now Rutgers Medical school).
Steven J. Davis, ESQ, Legal Counsel
Mr. Davis has over 27 years experience in corporate and business law. His experience ranges from serving on the Board of Directors of Philter Labs, Inc., and on the Board of Directors and Audit, Compensation and Nominating Committees of Telanetix, Inc. Prior to starting his own practice, Mr. Davis served as General Counsel and an executive officer of Molecular Imaging Corporation, and as in-house counsel for Leap Wireless International, Inc. He also practiced in the Business and Corporate Group in the San Diego office of Luce, Forward, Hamilton & Scripps LLP (now Dentons), a full-service law firm with over 200 attorneys, where he advised both private and public clients. Mr. Davis is licensed to practice law in California, the District of Columbia, and Minnesota. He received his Juris Doctor, Cum Laude, from the University of San Diego, School of Law in 1992. He received his B.A. in Political Science, Cum Laude, from Arizona State University in 1988.
Stuart Greene, VP of Marketing and Business Development
Mr. Greene has over 20 years of experience in Business Development, Enterprise Technology Sales and Marketing. His experience includes direct B2B sales, Enterprise Software Sales, Business Development and Marketing, as well as IBM Power Systems Sales and management of server and cloud services teams. He has extensive experience in C-Level Business Development, and creation and editing of direct marketing content and campaigns. Mr. Greene has a Bachelor of Arts degree in Communications from Muhlenberg College.
Professor Renping Zhou
Mr. Zhou is the current Chairperson and Professor in the Department of Chemical Biology at Rutgers University in New Jersey. He has 36 years of experience in cancer research, has been awarded multiple grants and has 62 peer reviewed publications.
Professor Xi Zheng
Mr. Zheng currently holds the positions of Director, Research Professor, Unilever Chair and Associate member at Rutgers Cancer Institute of New Jersey. He has 37 years of experience in cell biology, cancer research, immunohistochemistry and immunocytochemistry. He holds 5 patents and inventions in cancer, and has 102 peer reviewed publications.
Professor Harold H. Lee
Professor Lee has more than 20 peer-review science papers in developmental biology and biotechnology. He holds 4 patents in biotechnology. He is also an author of 4 novels.